Special Offer - Free Trial of Blockbuster.com
<http://media.adrevolver.com/adrevolver/href?banner=219326&nouid&place=30838&rnd=1292003846>
Rent Movies from Blockbuster.com. Delivered Direct To Your Mailbox.
Click here to start today.
<http://media.adrevolver.com/adrevolver/href?banner=219326&nouid&place=30838&rnd=1292003846>
----------------------------------------------------------------------------------------------------------
Friday, December 10, 2010 9:57 AM PST
Your Health News Alert for [cancer]
matched the following stories:
Spinner, Fri, 10 Dec 2010 09:54 AM PST
James Moody, Jazz Saxophonist and Flutist, Dead at 85 http://www.spinner.com/2010/12/10/james-moody-saxophonist-dead/
James Moody, the outsized jazz saxophonist and flutist best known for his recorded performance of 'I'm in the Mood for Love,' died Friday, Dec. 10 following a battle with pancreatic cancer. According to the New York Times , the 85-year-old passed away in a hospice in San Diego. Moody was one of the last in the lineage that can be traced back to the founding fathers of bebop. He was born in ...
Los Angeles Times, Fri, 10 Dec 2010 09:49 AM PST
Breast cancer drug combination with pertuzumab is effective http://www.latimes.com/health/boostershots/la-heb-herceptin-20101210,0,2282346.story?track=rss
The breast cancer drug pertuzumab when added to Herceptin improved the treatment of women with early-stage, HER-2 positive breast cancer, researchers reported Friday at the annual meeting of the San Antonio Breast Cancer Symposium .
6abc Philadelphia, Fri, 10 Dec 2010 09:46 AM PST
Saxophonist James Moody dies of pancreatic cancer http://abclocal.go.com/wpvi/story?section=news/entertainment&id=7836482&rss=rss-wpvi-article-7836482
Jazz saxophonist James Moody, who recorded more than 50 solo albums has died. He was 85.
Keokuk Daily Gate City, Fri, 10 Dec 2010 09:43 AM PST
Hamilton women make a difference with Pantene Beautiful Lengths donation http://www.dailygate.com/articles/2010/12/10/news/doc4cffead8879fd004418498.txt
Lacy Helenthal goes to great lengths to help women with cancer. Helenthal of Hamilton, and Mari Taylor, also of Hamilton, recently repeated what they started five years ago with a hair donation to Pantene Beautiful Lengths.
Brandon Sun, Fri, 10 Dec 2010 09:35 AM PST
Drug combo helps women with early breast cancer more than one drug alone: study http://www.brandonsun.com/lifestyles/breaking-news/study-herceptin-plus-tykerb-helps-women-with-early-breast-cancer-more-than-either-drug-alone-111663124.html?viewAllComments=y
SAN ANTONIO - New drug combinations are helping women with early breast cancer. Using two drugs that more precisely target tumours doubled the number of women whose cancer disappeared compared to those who had only one of the drugs, doctors reported Friday.
Medical News Today, Fri, 10 Dec 2010 09:33 AM PST
Exemestane May Be Another First-Line, Adjuvant Therapy For Hormone-Receptor Positive, Early-Stage Breast Cancer http://mnt.to/f/3NT2
Exemestane, an aromatase inhibitor that blocks production of estrogen, may provide another post-surgery option for postmenopausal women with hormone-receptor positive, early-stage breast cancer. In the first head-to-head adjuvant clinical trial comparing two aromatase inhibitors, anastrozole and exemestane, the drugs resulted in similar survival rates and prevention of breast cancer recurrences ...
Medical News Today, Fri, 10 Dec 2010 09:33 AM PST
Study Shows Novartis Drug Afinitor® Plus Hormonal Therapy Delays Disease Progression In Advanced Metastatic Breast ... http://mnt.to/f/3NT5
A new study shows that the addition of everolimus (Afinitor® tablets) to the hormonal therapy tamoxifen in patients with hormone-receptor positive/human epidermal growth factor receptor 2-negative (HR+/HER2-) metastatic breast cancer who have been previously treated with an aromatase inhibitor (AI) delays disease progression compared to tamoxifen alone. These results were presented today at the ...
PhysOrg, Fri, 10 Dec 2010 09:33 AM PST
Simple fingertip test may identify breast cancer patients at risk for carpal tunnel syndrome http://www.physorg.com/news/2010-12-simple-fingertip-breast-cancer-patients.html
A gene target for drug resistance, a triple-drug cocktail for triple negative breast cancer, and patients' risk for carpal tunnel syndrome are among study highlights scheduled to be presented by Johns Hopkins Kimmel Cancer Center scientists during the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium, held Dec. 8-12.
Medical News Today, Fri, 10 Dec 2010 09:32 AM PST
Syndax Pharmaceuticals' Entinostat Plus Erlotinib Improves Survival In Select NSCLC Patients http://mnt.to/f/3NT8
Syndax Pharmaceuticals, Inc., a clinical-stage epigenetics oncology company, announces clinical results from ENCORE 401, a double-blind, placebo-controlled phase 2 trial, in patients with advanced non-small cell lung cancer (NSCLC). The results show that there was a survival advantage in the subset of patients with elevated E-cadherin (a molecular marker of epithelial tumors) receiving ...
Medical News Today, Fri, 10 Dec 2010 09:32 AM PST
New Subgroup Analysis Of LUX-Lung 1 Trial Suggests Afatinib Increases Progression-Free Survival In Advanced Lung ... http://mnt.to/f/3NT9
Boehringer Ingelheim Pharmaceuticals, Inc. announced that new data from a subgroup analysis of the phase IIb/III LUX-Lung 1 trial show that afatinib (BIBW 2992) reached a four-fold extension (4.4 months vs. 1.0 month for placebo) in progression-free survival (PFS) in advanced non-small cell lung cancer (NSCLC) patients most likely to have an epidermal growth factor receptor (EGFR) mutation.(1 ...
See more health stories that match your keyword at:
http://search.news.yahoo.com/search/news/?fr=yalerts-health&c=&p=cancer+%2bcat%3ahealth&ei=utf-8
Visit Yahoo! Health:
http://health.yahoo.com/
You received this email because you subscribed to Yahoo! Alerts. Use http://us.rd.yahoo.com/alerts/b/email/unsubscribe/*http://alerts.yahoo.com/unsubscribe.php?id=sXMRy20uNLOb61vcJqT6947kyMX8._qi7bSZv83Y8dWR9ucl5enwTNw9PB1V6BoSpzxew03ianqAzSSdlXMCeth3O0AB3YzVvE_3 to unsubscribe from this alert.
To change your communications preferences for other Yahoo! business lines, please visit your Marketing Preferences: http://login.yahoo.com/config/login_verify2?.done=http://subscribe.yahoo.com/showaccount .
To learn more about Yahoo!'s use of personal information, please read our privacy policy at http://privacy.yahoo.com/privacy/us/ .
Yahoo! is located at 701 First Avenue, Sunnyvale, CA 94089.
